First Case Performed Using Natus XactTrode™ Subdural Electrodes

Rhea-AI Summary

Natus Medical (NASDAQ:NTUS) has successfully completed its first clinical case using the newly launched XactTrode™ family of platinum subdural electrodes, aimed at epilepsy surgical monitoring. These electrodes are designed for temporary use (<30 days) to capture and stimulate electrical signals on the brain's surface. CEO Jonathan Kennedy expressed satisfaction with their performance and compatibility with Natus’ Quantum system, enhancing operational efficiency for healthcare teams. The XactTrodes are now available to enhance surgical options for patients with central nervous system disorders.

Positive

• Successful clinical case completed with XactTrode electrodes.
• XactTrodes designed for superior anatomical fit and signal performance.
• Compatible with Natus' leading Quantum system for improved efficiency.

Negative

• None.

Launch to US Market of XactTrodes for Epilepsy Surgical Monitoring

PLEASANTON, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, is pleased to announce the completion of the first successfully performed clinical case using Natus’ newly launched XactTrode™ family of platinum subdural electrodes. The Natus XactTrodes are intended for temporary (< 30 days) use with recording, monitoring and stimulation of electrical signals on the surface of the brain.

“We are pleased that the surgical team found the XactTrodes to be an excellent solution for both anatomic fit and signal performance,” says Jonathan Kennedy, Natus CEO. “Natus is thrilled to now offer XactTrodes to our customers. We designed them to work seamlessly with our market leading Quantum system, which will provide care teams greater efficiency and performance.”

For more information about XactTrodes, please visit https://neuro.natus.com/products-services/subdural-electrodes.

About Natus Medical Incorporated

Natus Medical Incorporated improves patient outcomes using the most comprehensive product solutions, depth of training and continuing customer care when diagnosing and treating central nervous and sensory system disorders for patients of all ages.

Additional information about Natus Medical Incorporated can be found at https://natus.com.

Contacts:
Natus Medical Incorporated
Drew Davies
Executive Vice President and Chief Financial Officer
(925) 223-6700
InvestorRelations@Natus.com                

FAQ

What are Natus Medical's XactTrodes used for?

Natus Medical's XactTrodes are used for recording, monitoring, and stimulation of electrical signals on the surface of the brain, specifically for epilepsy surgical monitoring.

When was the first clinical case using XactTrodes completed?

The first clinical case using Natus Medical's XactTrodes was completed successfully on August 3, 2021.

How do XactTrodes improve surgical monitoring?

XactTrodes provide excellent anatomical fit and signal performance, enhancing the efficiency and effectiveness of surgical teams during monitoring.

Where can I find more information about XactTrodes?

More information about XactTrodes can be found on Natus Medical's official website.